Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mauricio Lema

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Journal of Clinical Medicine|January 28, 2026
Evidence-Based Consensus on the Diagnosis and Treatment of Advanced HER2-Positive and HER2-Low Breast Cancer in ColombiaMauricio Lema, Luz F Sua, Abrahám José Hernández Blanquisett, et al.
Hereditary Cancer in Clinical Practice|April 19, 2014
Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from medellín, ColombiaJulián Esteban Londoño Hernández, Marcia Llacuachaqui, Gonzalo Vásquez Palacio, et al.
The Oncologist|March 27, 2019
Personalizing Precision Oncology Clinical Trials in Latin America: An Expert Panel on Challenges and OpportunitiesRoberto Jun Arai, Rodrigo Santa Cruz Guindalini, Andrea Sabina Llera, et al.
Advances in Therapy|October 21, 2019
Real-World Effectiveness and Tolerability of Pazopanib as First Targeted Therapy in Metastatic Renal Cell Carcinoma: A Retrospective Chart Review in Latin AmericaDavid Queiroz Muniz, Barbara Ratto, Hongbo Yang, et al.
JCO Global Oncology|May 22, 2023
Clinical Outcomes and Prognostic Factors of Patients With Early Malignant Melanoma in One Latin American Country: Results of the Epidemiological Registry of Malignant Melanoma in Colombia StudyAylen Vanessa Ospina Serrano, Fernando Contreras, Iván Triana, et al.
Oncology|March 7, 2018
Real-World Treatment Patterns, Survival, and Prediction of CNS Progression in ALK-Positive Non-Small-Cell Lung Cancer Patients Treated with First-Line Crizotinib in Latin America Oncology PracticesClaudio Martín, Andrés F Cardona, Zyanya Lucia Zatarain-Barrón, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|February 10, 2023
Real-world evidence of nivolumab for non-small-cell lung cancer in a developing countryMauricio Luján, Mauricio Lema, Beatriz Preciado, et al.
JCO Global Oncology|September 10, 2021
Practice-Changing Use of the 21-Gene Test for the Management of Patients With Early-Stage Breast Cancer in Latin AmericaHenry L Gomez, Juan E Bargallo-Rocha, Roberto J Billinghurst, et al.
Journal of Clinical Medicine|November 13, 2025
Optimization of the Use of Generic Medications in Oncology: Improving Safety and Therapeutic QualityDiego Gómez Abreo, Daniel F Alarcón Cano, Fernando Ayala, et al.
Human Genomics|June 18, 2024
Germline mutations of breast cancer susceptibility genes through expanded genetic analysis in unselected Colombian patientsDiana Carolina Sierra-Díaz, Adrien Morel, Dora Janeth Fonseca-Mendoza, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Journal of Clinical Medicine|January 28, 2026
Evidence-Based Consensus on the Diagnosis and Treatment of Advanced HER2-Positive and HER2-Low Breast Cancer in ColombiaMauricio Lema, Luz F Sua, Abrahám José Hernández Blanquisett, et al.
Hereditary Cancer in Clinical Practice|April 19, 2014
Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from medellín, ColombiaJulián Esteban Londoño Hernández, Marcia Llacuachaqui, Gonzalo Vásquez Palacio, et al.
The Oncologist|March 27, 2019
Personalizing Precision Oncology Clinical Trials in Latin America: An Expert Panel on Challenges and OpportunitiesRoberto Jun Arai, Rodrigo Santa Cruz Guindalini, Andrea Sabina Llera, et al.
Advances in Therapy|October 21, 2019
Real-World Effectiveness and Tolerability of Pazopanib as First Targeted Therapy in Metastatic Renal Cell Carcinoma: A Retrospective Chart Review in Latin AmericaDavid Queiroz Muniz, Barbara Ratto, Hongbo Yang, et al.
JCO Global Oncology|May 22, 2023
Clinical Outcomes and Prognostic Factors of Patients With Early Malignant Melanoma in One Latin American Country: Results of the Epidemiological Registry of Malignant Melanoma in Colombia StudyAylen Vanessa Ospina Serrano, Fernando Contreras, Iván Triana, et al.
Oncology|March 7, 2018
Real-World Treatment Patterns, Survival, and Prediction of CNS Progression in ALK-Positive Non-Small-Cell Lung Cancer Patients Treated with First-Line Crizotinib in Latin America Oncology PracticesClaudio Martín, Andrés F Cardona, Zyanya Lucia Zatarain-Barrón, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|February 10, 2023
Real-world evidence of nivolumab for non-small-cell lung cancer in a developing countryMauricio Luján, Mauricio Lema, Beatriz Preciado, et al.
JCO Global Oncology|September 10, 2021
Practice-Changing Use of the 21-Gene Test for the Management of Patients With Early-Stage Breast Cancer in Latin AmericaHenry L Gomez, Juan E Bargallo-Rocha, Roberto J Billinghurst, et al.
Journal of Clinical Medicine|November 13, 2025
Optimization of the Use of Generic Medications in Oncology: Improving Safety and Therapeutic QualityDiego Gómez Abreo, Daniel F Alarcón Cano, Fernando Ayala, et al.
Human Genomics|June 18, 2024
Germline mutations of breast cancer susceptibility genes through expanded genetic analysis in unselected Colombian patientsDiana Carolina Sierra-Díaz, Adrien Morel, Dora Janeth Fonseca-Mendoza, et al.
Pageof 3